期刊文献+

嵌合体检测在脐血造血干细胞移植中的应用 被引量:1

原文传递
导出
摘要 脐带血已越来越多地成为造血干细胞移植的供源。造血重建的延迟及原发性移植失败率的上升仍然阻碍脐带血移植的广泛应用。移植后有效嵌合状态的动态检测,将可以预测植入失败、指导免疫抑制剂调整和尽早挽救治疗,从而改善脐带血移植结果,提高患者的生存率。现就嵌合体的检测在脐带血移植中的应用进行综述。
出处 《国际输血及血液学杂志》 CAS 2012年第2期160-162,共3页 International Journal of Blood Transfusion and Hematology
基金 安徽省临床医学技术应用项目(2008A011) 安徽省高校省级自然科学重点研究项目(KJ2008A17ZC)
  • 相关文献

参考文献25

  • 1Anderson D, Billingham RE, Lampkin GH, et al. The use of skin grafting to distinguish between monzygotic and dizygotic twins in cattle. Heredity, 1951,5: 379-397.
  • 2Ford CE, Hamerton JL, Loutit JF, et al . Cytological identification of radiation-chimaeras. Nature, 1956, 177 ( 4506 ) : 452-454.
  • 3Dubovsky J, Daxberger H, Fritsch G, et al. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection. Leukemia, 1999,13(12) :2059-2069.
  • 4Bader P,Beek J, Frey A,et al. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant, 1998,21 (5) : 487-495.
  • 5Balon J, Halaburda K, Bieniaszewska M, et al. Early complete donor hematopoietie ehimerism in peripheral blood indicates the risk of extensive graft-versus-host disease. Bone Marrow Transplant, 2005,35 ( 11 ) : 1083-1088.
  • 6Mohty M, Avinens O, Faucher C, et al. Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation. Haematologica, 2007,92 (7) : 1004-1006.
  • 7Malard F,Szydlo RM, Brissot E, et al. Impact of cyelosporine-A coneentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant, 2010, 16(1): 28-34.
  • 8Barker JN,Weisdorf DJ, DeFor TE, et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood, 2003,102(5) :1915-1919.
  • 9Antin JH, Childs R, Filipovich AH, et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant, 2001,7 (9) : 473-485.
  • 10Thiede C,Kellermann T,Schwerdtfeger R, et al. Real-time PCR for the SRY-gene allows sensitive and quantitative chimerism analysis after allogeneic blood stem cell transplantation: clinical results in 43 patients. Bone Marrow Transplant,2003, 31: S23.

二级参考文献20

  • 1Rocha V,Cornish J,Sievers EL,et al.Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.Blood,2001,97:2962-2971.
  • 2Eapen M,Rubinstein P,Zhang MJ,et al.Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia:a comparison study.Lancet,2007,369:1947-1954.
  • 3Barker JN,Weisdorf DJ,DeFor TE,et al.Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with malignancy.Blood,2005,105:1343-1347.
  • 4Lekakis L,Giralt S,Couriel D,et al.Phase Ⅱ study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies.Bone Marrow Transplant,2006,38:421-426.
  • 5Brunstein CG,Barker JN,Weisdorf DJ,et al.Umbilical cord blood transplantation after nonmyeloablative conditioning:impact on transplantation outcomes in 110 adults with hematologic disease.Blood,2007,110:3064-3070.
  • 6Glucksberg H,Storb R,Fefer A,et al.Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLAmatched sibling donors.Transplantation,1974,18:295-304.
  • 7Huang XJ,Wang Y,Liu DH,et al.Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advancedleukemia-feasibility and safety study.J Clin Immunol,2008,28:390-397.
  • 8Cornetta K,Laughlin M,Carter S,et al.Umbilical cord blood transplantation in adults:results of the prospective Cord Blood Transplantation(IOBLT).Biol Blood Marrow Transplant,2005,11:149-160.
  • 9Ooi J,Takahashi S,Tomonari A,et al.Unrelated cord blood transplantation after myeloablative conditioning in adults with acute myelogenous leukemia.Biol Blood Marrow Transplant,2008,14:1341-1347.
  • 10Saavedra S,Sanz GF,Jarque I,et al.Early infections in adult patients undergoing unrelated donor cord blood transplantation.Bone Marrow Transplant,2002,30:937-943.

共引文献14

同被引文献15

  • 1王昱,潘凯枫,陆道培.异基因造血干细胞移植植活状态的变性高效液相色谱检测研究的首次报告[J].中国实验血液学杂志,2005,13(1):9-15. 被引量:3
  • 2姚雯(综述),孙自敏(审校).脐带血干/祖细胞的体外扩增实验研究进展[J].国际儿科学杂志,2007,34(3):202-205. 被引量:2
  • 3Gluckman E, Rocha V. Cord blood transplantation: state of the art[J]. Haematologica, 2009,94(4):451-454.
  • 4Gluckman E, Broxmeyer H A, Auerbaeh A D, et al. Hemato- poietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood froman HLA-identical sibling [J]. N Engl J Med, 1989,321:1174-1178.
  • 5Eapen M, Rubinstein P, Zhang M J, et al. Outcomes of trans- plantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study [J]. Lancet, 2007,369:1947-1954.
  • 6Takahashi S, Ooi J, Tomonari A, et al. Comparative single-in- stitute analysis of cord blood transplantation from unrelated do- nors with bone marrow or peripheral blood stem-eell trans- plants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen[J]. Blood, 2007,109:1322-1330.
  • 7Elia L, Arcese W, Torello M, et al. HLA-C and HLA-DQBI compatibility in unrelated cord blood transplants[J]. Haemato- logica, 1999,84:530-534.
  • 8Tse W, Bunting K D, Laughlin M J. New insights into cord blood stem cell transplantation[J]. Curr Opin Hematol, 2008,15: 279-284.
  • 9Wagner J E, Barker J N, DeFor T E, et al. Transplantationof unrelated donor umbilical cord bloodin 102 patients with ma- lignant and nonmalignantdiseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival[J]. Blood. 2002.100:1611-1618.
  • 10Barker J N, Weisdoff D J, of 2 partially HLA-matched hanceengraonent in adults Blood, 2005,105:1343-1347.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部